Optimizing the use of checkpoint inhibitors in cancer. Focusing on biomarkers for patient selection and immunogenic effects of conventional cancer therapies
The thesis was published by
Wilpe, S. van,
in January 2022,
Radboud University Nijmegen.
Abstract:
The full thesis can be downloaded at :
https://repository.ubn.ru.nl//bitstream/handle/2066/249063/249063.pdf
https://repository.ubn.ru.nl//bitstream/handle/2066/249063/249063.pdf